Skip to main content
PEPG
NASDAQ Life Sciences

DSMB Greenlights Highest Dose Cohort for PepGen's DM1 Therapy, Data Readouts Set

Tom Rudovsky · Reported by BusinessWire
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$1.96
Mkt Cap
$136.955M
52W Low
$1.01
52W High
$7.8
52W Position info
94% above low
Off High info
75% below high
Rel. Volume info
0.8× avg
Market data snapshot near publication time

PEPG sits 94% above its 52-week low of $1.01.

Summary

An independent safety board cleared PepGen to escalate its lead DM1 drug to the highest planned dose after reviewing data from the fully enrolled 10 mg/kg cohort. No serious safety signals emerged, and 6 of 8 patients from the lower dose opted into the extension study, signaling tolerability. The company now has a clear catalyst path: 10 mg/kg cohort results in November, followed by the 12.5 mg/kg data in the first half of 2027, with an OLE update by early January. This de-risks the program and sets up a potential end-of-Phase 2 meeting with regulators in 2027. With a $137M market cap and cash runway into H2 2027, positive data could materially change the company's valuation.

Updates

  1. · SEC 8-K — PepGen reported Q2 2026 financial results: cash of $117.2M as of June 30, 2026, sufficient into Q4 2027; R&D expenses $12.5M; net loss $17.8M or $0.26 per share.

At the time of this announcement, PEPG was trading at $1.96 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $137M. The 52-week trading range was $1.01 to $7.80. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: BusinessWire.


Price Chart

Share this article

Copied!

PEPG - Latest Insights

PEPG
Nov 17, 2026, 4:07 PM EST
Filing Type: 4
Importance Score:
8
Price at Filing: $3.89
Real-time Price: $4.01 info
Change: +$0.115 (+3%) info
Market Cap: $277.738M info
PEPG
Nov 11, 2026, 10:22 PM EST
Source: BusinessWire
Importance Score:
7
Price at Filing: $5.35
Real-time Price: $4.01 info
Change: -$1.34 (-25%) info
Market Cap: $277.738M info
PEPG
Nov 10, 2026, 4:23 PM EST
Source: BusinessWire
Importance Score:
8
Price at Filing: $4.89
Real-time Price: $4.01 info
Change: -$0.880 (-18%) info
Market Cap: $277.738M info
PEPG
Nov 10, 2026, 7:05 AM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $2.40
Real-time Price: $4.01 info
Change: +$1.61 (+67%) info
Market Cap: $277.738M info
PEPG
Nov 10, 2026, 7:01 AM EST
Source: BusinessWire
Importance Score:
8
Price at Filing: $2.40
Real-time Price: $4.01 info
Change: +$1.61 (+67%) info
Market Cap: $277.738M info